Literature DB >> 4370200

Mode of action of chronotropic agents in cardiac Purkinje fibers. Does epinephrine act by directly modifying the external surface charge?

R W Tsien.   

Abstract

Hauswirth et al. (1968) proposed that epinephrine acts on i(KK2) by adding its own positive charge to the external membrane surface near the i(KK2) channel. This hypothesis was tested by using noncationic compounds, theophylline and R07-2956, which mimicked epinephrine's effects on pacemaker activity and on i(KK2). In maximally effective doses, theophylline or R07-2956 occluded the effect of epinephrine, indicating a shared final common mechanism. Since theophylline and R07-2956 are noncationic at pH 7.4, the common mechanism cannot be a direct change in external surface charge. On the contrary, epinephrine does not interfere with the voltage shift produced by La(+++), which is thought to modify the external surface charge. The results argue against the original hypothesis but leave open the possibility that an alteration in internal surface charge generates the observed voltage shift. The potency of theophylline and R07-2956 as phosphodiesterase inhibitors suggests that the final common mechanism begins with the elevation of intracellular cyclic AMP, leading to a saturable process which limits the voltage shift's magnitude. This hypothesis is used to generate dose-response curves describing the combined effects of epinephrine and theophylline, and these are compared with experimental data.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4370200      PMCID: PMC2226176          DOI: 10.1085/jgp.64.3.320

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  18 in total

1.  The potentiation of cardiac inotropic responses to norepinephrine by theophylline.

Authors:  T W RALL; T C WEST
Journal:  J Pharmacol Exp Ther       Date:  1963-03       Impact factor: 4.030

2.  Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibres.

Authors:  S WEIDMANN
Journal:  J Physiol       Date:  1955-09-28       Impact factor: 5.182

3.  Cyclic AMP mediates the effects of adrenaline on cardiac purkinje fibres.

Authors:  R W Tsien; W Giles; P Greengard
Journal:  Nat New Biol       Date:  1972-12-06

4.  Cyclic adenosine 3',5'-monophosphate-dependent protein kinase stimulation of calcium uptake by canine cardiac microsomes.

Authors:  M A Kirchberger; M Tada; D I Repke; A M Katz
Journal:  J Mol Cell Cardiol       Date:  1972-12       Impact factor: 5.000

5.  Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog.

Authors:  L D Davis; J V Temte
Journal:  Circ Res       Date:  1968-05       Impact factor: 17.367

6.  The effect of epinephrine on adenosine 3', 5'-phosphate levels in the isolated perfused rat heart.

Authors:  G A Robison; R W Butcher; I Oye; H E Morgan; E W Sutherland
Journal:  Mol Pharmacol       Date:  1965-09       Impact factor: 4.436

7.  Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase.

Authors:  H Sheppard; G Wiggan
Journal:  Mol Pharmacol       Date:  1971-01       Impact factor: 4.436

8.  Adrenaline: mechanism of action on the pacemaker potential in cardiac Purkinje fibers.

Authors:  O Hauswirth; D Noble; R W Tsien
Journal:  Science       Date:  1968-11-22       Impact factor: 47.728

9.  The control of membrane ionic currents by the membrane potential of muscle.

Authors:  H JENERICK
Journal:  J Gen Physiol       Date:  1959-05-20       Impact factor: 4.086

10.  Effects of epinephrine on the pacemaker potassium current of cardiac Purkinje fibers.

Authors:  R W Tsien
Journal:  J Gen Physiol       Date:  1974-09       Impact factor: 4.086

View more
  26 in total

1.  The relation between the current underlying pacemaker activity and beta-adrenoceptors in cardiac Purkinje fibres: a study using adrenaline, procaine, atenolol and penbutolol.

Authors:  K Hashimoto; O Hauswirth; H D Wehner; R Ziskoven
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-05       Impact factor: 3.000

2.  Effects of protein kinase inhibitors on canine Purkinje fibre pacemaker depolarization and the pacemaker current i(f).

Authors:  F Chang; I S Cohen; D DiFrancesco; M R Rosen; C Tromba
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

3.  The effect of verapamil and dibutyryl cAMP on the spontaneous activity of the sinus node.

Authors:  W Tuganowski; P Kopéc; M Kopyta; J Wezowska
Journal:  Experientia       Date:  1977-05-15

4.  Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node.

Authors:  D DiFrancesco; A Ferroni; M Mazzanti; C Tromba
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

5.  The effects of isoprenaline and a new beta-sympathomimetic amine upon spontaneous activity, diastolic depolarization and plateau height in cardiac Purkinje fibres.

Authors:  W Grabowski; H C Lüttgau; J J Schulze
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

6.  Pacemaker current i(f) in adult canine cardiac ventricular myocytes.

Authors:  H Yu; F Chang; I S Cohen
Journal:  J Physiol       Date:  1995-06-01       Impact factor: 5.182

7.  Epinephrine and the pacemaking mechanism at plateau potentials in sheep cardiac Purkinje fibers.

Authors:  A J Pappano; E E Carmeliet
Journal:  Pflugers Arch       Date:  1979-10       Impact factor: 3.657

8.  Pace-maker current changes during intracellular pH transients in sheep cardiac Purkinje fibres.

Authors:  P P Van Bogaert
Journal:  Pflugers Arch       Date:  1985-05       Impact factor: 3.657

9.  The ionic basis of concentration-related effects of noradrenaline on the action potential of calf cardiac purkinje fibres.

Authors:  R S Kass; S E Wiegers
Journal:  J Physiol       Date:  1982-01       Impact factor: 5.182

10.  Alinidine modifies the pacemaker current in sheep Purkinje fibers.

Authors:  D J Snyders; P P Van Bogaert
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.